Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate
2006-05-02
2006-05-02
Mosher, Mary E. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
C424S202100, C424S204100, C424S214100, C424S229100, C424S222100, C424S216100, C424S207100, C424S211100, C424S225100, C424S233100, C424S232100, C435S235100, C435S320100, C514S04400A
Reexamination Certificate
active
07037506
ABSTRACT:
The present invention provides a vaccine accelerator factor (VAF) which is an in ovo nucleotide immuno-stimulant. The VAF contains one or more DNA constructs, each having a DNA molecule and a vector. Each of the DNA molecule contains one or more genes or gene fragments, each encoding an antigenic peptide of an avian virus. The VAF is preferably administered to the amniotic fluid of an egg after being fertilized for about 17–19 days. The VAF can be co-administered with a viral vaccine containing one or more attenuated or inactive avian viruses. Alternatively, the VAF can be administered prior to the administration of the viral vaccine, which is administered at hatch or post-hatch. The VAF stimulates and accelerate a protective immune response of a viral vaccine.
REFERENCES:
patent: 4458630 (1984-07-01), Sharma et al.
patent: 5056464 (1991-10-01), Lewis
patent: 5397568 (1995-03-01), Whitfill et al.
patent: 5397569 (1995-03-01), Whitfill et al.
patent: 5595912 (1997-01-01), Vakharia et al.
patent: 5643578 (1997-07-01), Robinson et al.
patent: 5699751 (1997-12-01), Phelps et al.
patent: 5750101 (1998-05-01), Stone
patent: 5780289 (1998-07-01), Vermeulen et al.
patent: 5817320 (1998-10-01), Stone
patent: 5871748 (1999-02-01), Whitfill et al.
patent: 6032612 (2000-03-01), Williams
patent: 6048535 (2000-04-01), Sharma
patent: 6136319 (2000-10-01), Whitfill et al.
patent: 6221362 (2001-04-01), Audonnet et al.
patent: 6286455 (2001-09-01), Williams
patent: 6299874 (2001-10-01), Whitfill et al.
patent: 6322780 (2001-11-01), Lee et al.
patent: WO 98/03659 (1998-01-01), None
Rollier et al (Vaccine 18:3091-3096,2000).
Kodihalli et al (Journal of Virology 71:3391-3396, 1997).
Oshop et al (Veterinary Immunology and Immunopathology 89:1-12, published Oct. 8, 2002).
Reddy et al (Vaccine 14:469-477, 1996).
deLeeuw et al (Journal of General Virology 80:131-136, 1999).
Zimmerman, Stefan et al., Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3' sequence modifications; Vaccine, vol. 21, pp. 990-995, 2003.
Johnston, P.A. et al., Applications in In Ovo Technology, Poultry Science, vol. 76, pp. 165-178, 1997.
Mosher Mary E.
Pai Patent & Trademark Law Firm
Schweltzer Chemical Corporation Ltd.
LandOfFree
Vaccine accelerator factor (VAF) for improvement of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine accelerator factor (VAF) for improvement of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine accelerator factor (VAF) for improvement of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3605142